These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Trials for the use of gamma rays in the prevention of Trypanosoma cruzi transfusion infection]. Amato Neto V; Pasternak J; Matsubara L; Hammerschlak N; Carignani FL Rev Soc Bras Med Trop; 1996; 29(6):613-4. PubMed ID: 9011890 [No Abstract] [Full Text] [Related]
8. A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization. Ortiz-Ortiz L; Gonzalez-Mendoza A; Lamoyi E J Immunol; 1975 Apr; 114(4):1424-5. PubMed ID: 804010 [No Abstract] [Full Text] [Related]
9. Biolistic DNA vaccination against Trypanosoma infection. Bryan M; Guyach S; Norris KA Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351 [TBL] [Abstract][Full Text] [Related]
10. Experimental Chagas' disease: studies on the stability of a protective antigen. Cappa SM; Cantarella AI; Lajmanovich S; Segura ES J Parasitol; 1976 Feb; 62(1):130-1. PubMed ID: 815532 [No Abstract] [Full Text] [Related]
11. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction? Basso B; Marini V Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810 [TBL] [Abstract][Full Text] [Related]
12. Vaccine development against Trypanosoma cruzi and Chagas disease. Vázquez-Chagoyán JC; Gupta S; Garg NJ Adv Parasitol; 2011; 75():121-46. PubMed ID: 21820554 [TBL] [Abstract][Full Text] [Related]
13. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model. Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408 [TBL] [Abstract][Full Text] [Related]
14. Protection against Trypanosoma cruzi using fecal forms of homologous parasites from juvenilized or normal vectors of Chagas' disease and by passive transfer of immune blood. Perlowagora-Szumlewicz A Rev Bras Malariol Doencas Trop; 1977; 29():5-21. PubMed ID: 120952 [No Abstract] [Full Text] [Related]
16. Experimental Chagas' disease: protective activity in relation with subcellular fractions of the parasite. Segura EL; Paulone I; Cerisola J; Cappa SM J Parasitol; 1976 Feb; 62(1):131-3. PubMed ID: 815533 [No Abstract] [Full Text] [Related]
17. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi. Basso B; Moretti E; Fretes R Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040 [TBL] [Abstract][Full Text] [Related]
18. [Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection]. Fernández de Lara WG Rev Inst Med Trop Sao Paulo; 1972; 14(5):301-5. PubMed ID: 4630386 [No Abstract] [Full Text] [Related]
19. Trypanosoma cruzi culture used as vaccine to prevent chronic Chagas' disease in mice. Basombrío MA; Besuschio S Infect Immun; 1982 Apr; 36(1):351-6. PubMed ID: 6804390 [TBL] [Abstract][Full Text] [Related]
20. Immunization of mice against infection with Trypanosoma cruzi. Cross-immunization between five strains of the parasite using freeze-thawed vaccines containing epimastigotes of up to five strains. McHardy N; Elphick JP Int J Parasitol; 1978 Feb; 8(1):25-31. PubMed ID: 415993 [No Abstract] [Full Text] [Related] [Next] [New Search]